Delivery Order SPE2DB22D2009-SPE2DB25FL9EK
Award Date
5/12/25
Potential Completion Date
5/13/25
Potential Value
$7.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,907.28 firm fixed-price contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of June 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with a firm fixed price ceiling value of $2,650.95 and a performance period ending on May 19, 2025. The contract is not set aside and was awarded on May 16, 2025. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of a specific pharmaceutical product, DAPAGLIFLOZIN 10 MG TABLET 30S. The contract has a ceiling value of $9,867.26 and is a firm fixed price delivery order contract, with a completion date of June 6, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $9,893.07 and a performance period through June 6, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568441720 DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication. The contract has a firm-fixed price of $11,722.30 and a period of performance through June 4, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a prescription medication. The contract has a firm fixed price of $1,416.72 and a completion date of May 19, 2025. This appears to be a non-set-aside contract, meaning it was awarded through open competition. Amerisourcebergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,522.35, is for the delivery of 4565069626 DAPAGLIFLOZIN 10 MG TABLET 30S, which are used for the treatment of diabetes. The contract has an ultimate completion date of July 5, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S. The contract is a firm fixed-price delivery order with a ceiling value of $4,013.65 and a period of performance through June 18, 2025. The award is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,464.90, is for the delivery of 4564986974 - Dapagliflozin 10 mg tablets in 30-count packages. The contract has a firm fixed price and is set to expire on June 25, 2024. This order is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,525.16 with a firm fixed price pricing type. The contract is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, with a performance period extending through June 13, 2025. The contract does not have a set-aside designation, indicating...